AJP - Renal AJP citation statistics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 290: F43-F51, 2006. First published August 2, 2005; doi:10.1152/ajprenal.00179.2005
0363-6127/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/1/F43    most recent
00179.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Covington, M. D.
Right arrow Articles by Parrish, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Covington, M. D.
Right arrow Articles by Parrish, A. R.

Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14)

Marisa D. Covington,1 Robert C. Burghardt,2 and Alan R. Parrish1

1Department of Medical Pharmacology and Toxicology, College of Medicine, Texas A&M University System Health Science Center, and 2Department of Veterinary Integrated Biosciences, College of Veterinary Medicine, Texas A&M University, College Station, Texas

Submitted 27 April 2005 ; accepted in final form 31 July 2005

Ischemia is a leading cause of acute renal failure (ARF), a disease associated with high morbidity and mortality. Disruption of intercellular adhesion in the proximal tubules is linked to ARF, although the molecular mechanism(s) remains unclear. Our previous studies showed that ischemia is associated with cadherin cleavage and loss in NRK cells, putatively due to a matrix metalloproteinase (MMP) (7). In the current studies, a MMP required for E-cadherin cleavage and N-cadherin loss was identified. Chemical inhibitors against a number of soluble MMPs (1, 2, 3, 8, 9) failed to completely attenuate ischemia-induced cadherin loss. Under ischemic conditions, there was an increase in active membrane-type (MT)1-MMP but a decrease in MMP-2 protein expression. Plating cells on fibronectin protected against ischemia-induced loss of cadherins and, interestingly, no increase in active MT1-MMP levels was seen in ischemic cells on fibronectin-coated dishes. In addition, L cells stably expressing E- (LE) or N-cadherin (LN), but lacking MT1-MMP expression, were resistant to ischemia-induced cadherin loss. The role of MT1-MMP in ischemia-induced cadherin loss was confirmed by either blocking MT1-MMP activity with a neutralizing antibody or expression with shRNA constructs which protected full-length E- and N-cadherin during ischemia. Using shRNA constructs to suppress MT1-MMP expression, ischemia-induced disruption of cadherin function was ablated, and cell-cell contacts were preserved. These results demonstrate that ischemia induces increased expression of active MT1-MMP and subsequent disruption of cadherin/catenin complexes, implying that MT1-MMP plays a role in ischemia-induced ARF.

shRNA; acute renal failure; proximal tubules



Address for reprint requests and other correspondence: A. R. Parrish, 364 Reynolds Medical Bldg., College Station, TX 77843-1114 (e-mail: parrish{at}medicine.tamhsc.edu)




This article has been cited by other articles:


Home page
Circ. Res.Home page
A. Bedel, A. Negre-Salvayre, S. Heeneman, M.-H. Grazide, J.-C. Thiers, R. Salvayre, and F. Maupas-Schwalm
E-Cadherin/{beta}-Catenin/T-Cell Factor Pathway Is Involved in Smooth Muscle Cell Proliferation Elicited by Oxidized Low-Density Lipoprotein
Circ. Res., September 26, 2008; 103(7): 694 - 701.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. D. Cowden Dahl, J. Symowicz, Y. Ning, E. Gutierrez, D. A. Fishman, B. P. Adley, M. S. Stack, and L. G. Hudson
Matrix Metalloproteinase 9 Is a Mediator of Epidermal Growth Factor-Dependent E-Cadherin Loss in Ovarian Carcinoma Cells
Cancer Res., June 15, 2008; 68(12): 4606 - 4613.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. Navaratna, P. G. McGuire, G. Menicucci, and A. Das
Proteolytic Degradation of VE-Cadherin Alters the Blood-Retinal Barrier in Diabetes
Diabetes, September 1, 2007; 56(9): 2380 - 2387.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Taniwaki, H. Fukamachi, K. Komori, Y. Ohtake, T. Nonaka, T. Sakamoto, T. Shiomi, Y. Okada, T. Itoh, S. Itohara, et al.
Stroma-Derived Matrix Metalloproteinase (MMP)-2 Promotes Membrane Type 1-MMP-Dependent Tumor Growth in Mice
Cancer Res., May 1, 2007; 67(9): 4311 - 4319.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Symowicz, B. P. Adley, K. J. Gleason, J. J. Johnson, S. Ghosh, D. A. Fishman, L. G. Hudson, and M. S. Stack
Engagement of Collagen-Binding Integrins Promotes Matrix Metalloproteinase-9-Dependent E-Cadherin Ectodomain Shedding in Ovarian Carcinoma Cells
Cancer Res., March 1, 2007; 67(5): 2030 - 2039.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. M. Catania, G. Chen, and A. R. Parrish
Role of matrix metalloproteinases in renal pathophysiologies
Am J Physiol Renal Physiol, March 1, 2007; 292(3): F905 - F911.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.